David B. Weiner

David B. Weiner (board member) discloses dealings in Inovio Pharmaceuticals, Inc. to SEC (Form 4). We count 39 filings; the first trade dates from 9 March 2017 and the latest from 26 February 2026.

The open-market record consists of 8 sales worth €432k, with no purchase. Besides market trades, the filings include 31 option exercises.

Most recently, on 27 February 2026, the filings show an option exercise in Inovio Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.